Last Price
87.84
Today's Change
+6.74 (8.31%)
Day's Change
86.58 - 89.97
Trading Volume
24,371,578
Market Cap
360 Billion
Shares Outstanding
4 Billion
Avg Volume
7,535,158
Avg Price (50 Days)
97.44
Avg Price (200 Days)
121.71
PE Ratio
29.70
EPS
2.96
Earnings Announcement
05-Feb-2025
Previous Close
81.10
Open
89.97
Day's Range
86.5805 - 89.97
Year Range
78.17 - 148.15
Trading Volume
24,408,748
1 Day Change
8.41%
5 Day Change
9.98%
1 Month Change
0.63%
3 Month Change
-22.82%
6 Month Change
-33.19%
Ytd Change
0.46%
1 Year Change
-16.43%
3 Year Change
84.24%
5 Year Change
187.88%
10 Year Change
289.37%
Max Change
54850.00%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.